PT-141 represents a cutting-edge cyclic melanocortin agonist that possesses potential in the treatment of sexual dysfunction. This novel compound functions by enhancing specific receptors across the body, resulting to augmented sexual performance. Preclinical studies have indicated that PT-141 could effectively address a variety of sexual dysfunct